Drug Type Small molecule drug |
Synonyms LPM 3770164, LPM-3770164, LPM3770164 + [1] |
Target |
Action inhibitors, modulators |
Mechanism VMAT2 inhibitors(Synaptic vesicular amine transporter inhibitors), σ1 receptor modulators(Sigma opioid receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tardive Dyskinesia | Phase 2 | China | 13 Jan 2025 | |
Huntington Disease | Phase 1 | China | 25 Feb 2022 |